Bristol-Myers Squibb Co
BMV:BMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
BMV:BMY
|
US |
|
N
|
Nike Inc
DUS:NKE
|
US |
|
R S Software (India) Ltd
NSE:RSSOFTWARE
|
IN |
|
Carter Bank and Trust
NASDAQ:CARE
|
US |
|
E
|
Environmental Group Ltd
ASX:EGL
|
AU |
|
F
|
F-Secure Oyj
OMXH:FSECURE
|
FI |
|
Genting Singapore Ltd
SGX:G13
|
SG |
|
Innocan Pharma Corp
F:IP40
|
IL |
|
C
|
Crayon Group Holding ASA
OSE:CRAYN
|
NO |
|
S
|
Silgan Holdings Inc
NYSE:SLGN
|
US |
|
Samsung SDI Co Ltd
KRX:006400
|
KR |
|
G
|
Gujarat Pipavav Port Ltd
NSE:GPPL
|
IN |
Wall St Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BMY is 1 093.66 MXN with a low forecast of 577.61 MXN and a high forecast of 1 360.63 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMY's stock price target?
Price Target
1 093.66
MXN
According to Wall Street analysts, the average 1-year price target for
BMY is 1 093.66 MXN with a low forecast of 577.61 MXN and a high forecast of 1 360.63 MXN.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -5%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 17%.